TaiCoo Biologics Q4 2025 Financials
NQ Score
53/100
N1 Content Completeness
3
AI Summary (NQ-processed)
TaiCoo Biologics Inc. reported an operating revenue of NT.005 billion and a net loss of NT61 million for Q4 2025, with basic EPS at -NT.51.
AI analysis data is not yet available.